Publikationen von R. Gold

Haghikia, A.; Fischer, M.; Hellwig, K.; Linker, R.; Chan, A.; Hohlfeld, R.; Gold, R.: Open use of natalizumab. Neutralising antibodies and clinical data. Nervenarzt 79 (6), S. 716 - 719 (2008)

Wiendl, H.; Toyka, K. V.; Rieckmann, P.; Gold, R.; Hartung, H. P.; Hohlfeld, R.: Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. Journal of Neurology 255 (10), S. 1449 - 1463 (2008)

Krumbholz, M.; Pellkofer, H.; Gold, R.; Hoffmann, L.; Hohlfeld, R.; Kümpfel, T.: Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies. Archives of Neurology 64, S. 1331 - 1333 (2007)

Gold, R.; Hartung, H. P.; Hohlfeld, R.: Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy. Deutsche Medizinische Wochenschrift 131 (1-2), S. 31 - 34 (2006)

Wiendl, H.; Kieseier, B. C.; Gold, R.; Hohlfeld, R.; Bendszus, M.; Hartung, H. P.: Revision of McDonald's new diagnostic criteria for multiple sclerosis. Nervenarzt 10, S. 1235 - 1245 (2006)

Gold, R.; Linington, C.: Glatiramer acetate treatment in Devic's neuromyelitis optica - Reply. Brain 126, S. E1 - E1 (2003)

Gold, R.; Linington, C.: Devic's disease: Bridging the gap between laboratory and clinic. Brain 125, S. 1425 - 1427 (2002)